The objective of this study is to evaluate the effectiveness and safety of endovascular therapy combined with 25% human albumin in the treatment of acute large vessel occlusive stroke.

开始日期2024-08-03

申办/合作机构

首都医科大学

[+1]

NCT06224777 / Completed临床2/3期IIT

Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.

The goal of this comparative, interventional randomized controlled trial is to use albumin during resuscitation in pediatric burn patients on day 2, as it can reduce extravasation of fluids and decrease the overall fluid requirements, along with mortality and maintain circulation.
Participants will be divided into 2 groups. Albumin will be administered additionally in group A, while only crystalloids will be used for resuscitation in group B.

开始日期2022-01-01

申办/合作机构

King Edward Medical University

100 项与 Albumin (Human)(CSL Behring) 相关的临床结果

登录后查看更多信息

100 项与 Albumin (Human)(CSL Behring) 相关的转化医学

登录后查看更多信息

100 项与 Albumin (Human)(CSL Behring) 相关的专利（医药）

登录后查看更多信息

项与 Albumin (Human)(CSL Behring) 相关的文献（医药）

2000-01-01·Clinical Infectious Diseases1区 · 医学

Enterobacter cloacae Bloodstream Infections Traced to Contaminated Human Albumin

1区 · 医学

Article

作者: William R. Jarvis ; Matthew J. Arduino ; Edward A. Fitzgerald ; Arline L. Smith ; Peter J. Bianchine ; Jerome I. Tokars ; Loretta A. Carson ; Nancy C. Hansen ; Jay S. Epstein ; Susan A. Wang

In August 1996, a patient in Kansas developed an Enterobacter cloacae bloodstream infection (BSI) shortly after receiving Albuminar, a brand of human albumin. Albuminar contamination was suspected. A case-control study of patients with primary gram-negative bacterial BSIs showed that patients with E. cloacae BSIs were significantly more likely than patients with non-E. cloacae gram-negative BSIs to have received Albuminar within 3 days of developing their BSIs (3 of 5 vs. 0 of 9; OR, undefined; P=.03). The E. cloacae isolate from the Kansas patient was found by pulsed-field gel electrophoresis to be identical to the isolate from the patient's Albuminar vial, to isolates from 2 previously unopened Albuminar vials, and to an isolate from a Wisconsin patient who had received Albuminar. A worldwide recall of approximately 116,000 Albuminar vials took place. This multistate outbreak was detected because of clinical astuteness and prompt reporting. Combined epidemiological and laboratory approaches are valuable when investigating potentially contaminated blood components and plasma derivatives.

100 项与 Albumin (Human)(CSL Behring) 相关的药物交易

登录后查看更多信息

研发状态

10 条最早获批的记录,

后查看更多信息

适应症	国家/地区	公司	日期
出血性休克	日本	CSL Behring KK	2009-01-08
烧伤	美国	CSL Behring AG	1976-07-23
低白蛋白血症	美国	CSL Behring AG	1976-07-23
休克	美国	CSL Behring AG	1976-07-23